BioSpace News Archive

Biotech Beach

Retrophin to Present at the 37th Annual J.P. Morgan Healthcare Conference

Retrophin, Inc. today announced that Stephen Aselage, chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019 at 11:00 a.m. PT (2:00 p.m. ET).

January 7, 2019
·
1 min read
BioMidwest

Esperion to Present at the 37th Annual J.P. Morgan Healthcare Conference

Esperion today announced that president and chief executive officer, Tim M. Mayleben, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 9, 2019 at 5:30 p.m. Pacific Time/ 8:30 p.m. Eastern Time.

January 7, 2019
·
4 min read
Drug Development

Verrica Achieves Positive Topline Results from Two Pivotal Phase 3 Clinical Trials of VP-102 in Patients with Molluscum Contagiosum

CAMP-1 and CAMP-2 Phase 3 pivotal trials for molluscum contagiosum both achieve statistical significance for the primary endpoint with p-values less than 0.0001

January 7, 2019
·
9 min read
Business

InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management

- Jason Marks appointed Chief Legal Officer / General Counsel

January 7, 2019
·
4 min read
Pharm Country

Vyome raises $22M to advance dermatology pipeline

Proceeds to finance phase 2b clinical trial for a drug with novel mechanism of action against moderate to severe acne

January 7, 2019
·
4 min read
Drug Development

Adocia Announces a Clinical Trial Evaluating BioChaperone® Lispro and Other Rapid-Acting Insulin Analogs Using iLetTM Bionic Pancreas

ADOCIA announced today the first home-use trial to test Adocia’s BioChaperone® Lispro in Beta Bionics autonomous insulin delivery system, the iLetTM.

January 7, 2019
·
5 min read
Business

Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer

Dr. Dube brings proven track record of global leadership built upon significant commercial and operational success

January 7, 2019
·
7 min read
Policy

Medigene AG: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors

A mechanism expected to overcome checkpoint blockade in T cells

January 7, 2019
·
4 min read
Drug Development

Galapagos starts first Phase 1 trial with Toledo compound

Novel target class with dual action in inflammatory disorders

January 7, 2019
·
4 min read
Egg metabolites in blood related to lower risk of type 2 diabetes

Consumption of one egg every day seems to associate with a blood metabolite profile that is related to a lower risk of type 2 diabetes, a new study conducted in the University of Eastern Finland shows.

January 7, 2019
·
2 min read